ºù«Ӱҵ

All publications

Journal articles

• Essat M, Cooper K, Bessey A, Clowes M, Chilcott JB & Hunter KD (2022) . Head & Neck.
• Bessey A, Chilcott J, Pandor A & Paisley S (2020) . International Journal of Neonatal Screening, 6(4).
• Bessey A, Chilcott J, Leaviss J, de la Cruz C & Wong R (2019) . International Journal of Neonatal Screening, 5(3).
• Harnan S, Tappenden P, Cooper K, Stevens J, Bessey A, Rafia R, Ward S, Wong R, Stein RC & Brown J (2019) . Health Technology Assessment, 23(30).
• Bessey A, Chilcott JB, Leaviss J & Sutton A (2018) . Orphanet J Rare Dis, 13(1), 179-179.
• Morrell CJ, Sutcliffe P, Booth A, Stevens J, Scope A, Stevenson M, Harvey R, Bessey A, Cantrell A, Dennis C-L , Ren S et al (2016) . Health Technology Assessment, 20(37), 1-414.
• Essat M, Tappenden P, Ren S, Bessey A, Archer R, Wong R, Lobo A & Hoque S (2016) . PharmacoEconomics, 34(3), 245-257.
• Rathbone J, Kaltenthaler E, Richards A, Tappenden P, Bessey A & Cantrell A (2013) . BMJ Open, 3(11), e003573.
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () . International Journal of Neonatal Screening, 10(3), 56-56.
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A () . International Journal of Neonatal Screening, 10(3), 49-49.

Conference proceedings papers

• Bessey A, Leaviss J, de la Cruz GC, Chilcott J & Wong R (2017) THE COST-EFFECTIVENESS OF SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID) IN THE UK NHS NEWBORN BLOODSPOT SCREENING PROGRAMME. VALUE IN HEALTH, Vol. 20(9) (pp A501-A501)
• Morrell J, Sutcliffe P, Stevenson M, Stevens J, Booth A, Scope A, Bessey A, Dennis C-L, Cantrell A, Barkham M , Churchill D et al (2015) . Journal of Reproductive and Infant Psychology, Vol. 33(3) (pp E3-E4), 13 September 2016 - 14 September 2016.
• Bessey A, Chilcott J, Pandor A & Paisley S (2014) . Value in Health, Vol. 17(7) (pp A531-A531)
• Bessey A, Whyte S, Minton J & Chilcott J (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A407-A407)
• Kaltenthaler E, Rathbone J, Tappenden P, Bessey A & Cantrell A (2012) . VALUE IN HEALTH, Vol. 15(7) (pp A455-A455)

Posters

• Bessey A, Chilcott J, Paisley S & Pandor A The cost-effectiveness of expanding the NHS newborn bloodspot screening programme to include homocystinuria (HCU), maple syrup urine disease (MSUD), glutaric aciduria type 1 (GA1), isovaleric acidaemia (IVA), and long-chain hydroxyl acyl-CoA dehydrogenase deficiency (LCHADD) (2014).
• Rathbone J, Kaltenthaler E, Tappenden P, Bessey A & Cantrell A Issues in the systematic review of drugs for rare diseases: A case study of Eculizumab for AHUS (2012).

Preprints

• Cooper K, Essat M, Clowes M, Chilcott J, Hunter K & Bessey A (2022) Diagnostic accuracy of biopsy versus full excision for diagnosis of oral cancer: A systematic review.